Follow this preprint
Higher plasma levels of chemokine CCL19 are associated with poor SARS-CoV-2 acute respiratory distress syndrome (ARDS) outcomes
Joseph Balnis, Alejandro P. Adam, Amit Chopra, Hau C. Chieng, Paul J. Feustel, Katherine A. Overmyer, Evgenia Shishkova, Joshua J. Coon, Harold A. Singer, Marc A. Judson, Ariel Jaitovich
doi: https://doi.org/10.1101/2020.05.21.20051300
Joseph Balnis
1Division of Pulmonary and Critical Care Medicine, Albany Medical College, Albany, NY
2Department of Molecular and Cellular Physiology, Albany Medical College, Albany, NY
Alejandro P. Adam
1Division of Pulmonary and Critical Care Medicine, Albany Medical College, Albany, NY
3Ophthalmology and Experimental Therapeutics, Albany Medical College, Albany, NY
Amit Chopra
1Division of Pulmonary and Critical Care Medicine, Albany Medical College, Albany, NY
Hau C. Chieng
1Division of Pulmonary and Critical Care Medicine, Albany Medical College, Albany, NY
Paul J. Feustel
4Neuroscience and Experimental Therapeutics, Albany Medical College, Albany, NY
Katherine A. Overmyer
5Morgridge Institute for Research, Madison, WI
Evgenia Shishkova
6Department of Biomolecular Chemistry, University of Wisconsin-Madison, Madison, WI
Joshua J. Coon
5Morgridge Institute for Research, Madison, WI
6Department of Biomolecular Chemistry, University of Wisconsin-Madison, Madison, WI
Harold A. Singer
2Department of Molecular and Cellular Physiology, Albany Medical College, Albany, NY
Marc A. Judson
1Division of Pulmonary and Critical Care Medicine, Albany Medical College, Albany, NY
Ariel Jaitovich
1Division of Pulmonary and Critical Care Medicine, Albany Medical College, Albany, NY
2Department of Molecular and Cellular Physiology, Albany Medical College, Albany, NY

Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC 4.0 International license.
Posted May 22, 2020.
Higher plasma levels of chemokine CCL19 are associated with poor SARS-CoV-2 acute respiratory distress syndrome (ARDS) outcomes
Joseph Balnis, Alejandro P. Adam, Amit Chopra, Hau C. Chieng, Paul J. Feustel, Katherine A. Overmyer, Evgenia Shishkova, Joshua J. Coon, Harold A. Singer, Marc A. Judson, Ariel Jaitovich
medRxiv 2020.05.21.20051300; doi: https://doi.org/10.1101/2020.05.21.20051300
Subject Area
Reviews and Context
0
Comment
0
TRIP Peer Reviews
0
Community Reviews
0
Automated Services
0
Blogs/Media
0
Author Videos
Subject Areas
- Addiction Medicine (420)
- Allergy and Immunology (744)
- Anesthesia (217)
- Cardiovascular Medicine (3208)
- Dermatology (270)
- Emergency Medicine (476)
- Epidemiology (13211)
- Forensic Medicine (19)
- Gastroenterology (887)
- Genetic and Genomic Medicine (5041)
- Geriatric Medicine (469)
- Health Economics (770)
- Health Informatics (3167)
- Health Policy (1121)
- Hematology (419)
- HIV/AIDS (997)
- Medical Education (467)
- Medical Ethics (125)
- Nephrology (512)
- Neurology (4783)
- Nursing (253)
- Nutrition (708)
- Oncology (2463)
- Ophthalmology (698)
- Orthopedics (277)
- Otolaryngology (336)
- Pain Medicine (318)
- Palliative Medicine (89)
- Pathology (528)
- Pediatrics (1272)
- Primary Care Research (546)
- Public and Global Health (7344)
- Radiology and Imaging (1662)
- Respiratory Medicine (962)
- Rheumatology (471)
- Sports Medicine (413)
- Surgery (532)
- Toxicology (69)
- Transplantation (227)
- Urology (199)